Joint Pain Forum – News you can use!
Earns the Arthritis Foundation Ease-of-Use Commendation
March 12, 2007
NASONEX(R) (mometasone furoate monohydrate) Nasal Spray 50mcg* delivery
device is the first nasal allergy spray acknowledged by the Arthritis
Foundation as easy-to-use for people with arthritis
KENILWORTH, N.J., Feb. 28
/PRNewswire-FirstCall/ -- Schering-Plough today announced that the
device used to deliver NASONEX(R) (mometasone furoate monohydrate)
nasal spray for the treatment of nasal allergy symptoms has received
the Arthritis Foundation's Ease-of-Use Commendation. The commendation
recognizes products that provide accessibility or ease-of-use for
people with arthritis as determined by an independent lab experienced
in the design and evaluation of products and individuals with various
forms of the chronic illness.
"Products that receive the Ease-of-Use
Commendation have been shown to make everyday tasks, like administering
a medication, easy and comfortable for people with arthritis," said
Mary Norman, Arthritis Foundation group vice president of strategic
The Arthritis Foundation created the
Ease-of-Use Commendation Program to encourage manufacturers to design
user-friendly products and packaging that could be recommended to the
nearly 46 million Americans who are affected by some form of arthritis.
The NASONEX delivery device is the first nasal allergy spray to have
the Ease-of-Use Commendation from the Foundation.
An estimated 37 million Americans suffer
from the symptoms of seasonal and perennial allergies. A nasal-inhaled
steroid, such as NASONEX, is a recommended first-line therapy for all
nasal symptoms of allergic rhinitis. NASONEX is the only once-daily
prescription intranasal corticosteroid approved to help prevent
seasonal nasal allergy symptoms in adults and children 12 years of age
and older when NASONEX is started 2 to 4 weeks prior to allergy season.
NASONEX is also the only intranasal corticosteroid approved to treat
nasal allergy symptoms, including nasal congestion, in patients as
young as 2 years of age.
Ease-of-Use Patient Survey
A separate consumer survey of NASONEX
users also demonstrates that the applicator is easy for patients to
use. In a survey of more than 1,500 NASONEX users and caregivers of
young children who use NASONEX, 98 percent of those surveyed found the
NASONEX applicator easy to use. NASONEX users also report that the mist
from the NASONEX applicator is easy to administer and that the NASONEX
applicator is easy to pump and press.
Users also indicate that the NASONEX nasal
-- Fits comfortably in the nostril (96
percent of all users surveyed)
-- Fits comfortably in the
hand (96 percent of all users surveyed)
-- Is appropriately
sized to administer the medicine (95 percent of all users surveyed)
-- Is comfortable to hold while administering a dose or mist in the
nose (94 percent of all users surveyed)
was performed in November 2006 to evaluate whether patients find the
NASONEX nasal spray applicator easy and comfortable to use and included
a sample of general NASONEX users (n=1,126), pediatric NASONEX users
(n=506), elderly NASONEX users (n=355) and arthritic NASONEX users
(n=562). The sample was recruited from the Synovate interactive online
panel and purchased sample.
Map | CONTACT